A rundown of recent Trump administration vaccine policy changes
[June 28, 2025]
By The Associated Press
The Trump administration continued to reshape U.S. health policy in
recent days with several moves that could change what vaccines people
can get to protect themselves from common illnesses.
Some of the changes are immediate, others are still being discussed, and
Health Secretary Robert F. Kennedy Jr. must still sign off on some.
Doctors’ groups have expressed alarm at the moves made by Kennedy, a
longtime anti-vaccine activist, and his appointees, who at times have
ignored well-established science. Nearly 80 medical groups, including
the American Medical Association, issued a statement backing vaccines
against common respiratory ailments as “among the best tools to protect
the public.”
“We come together as physicians from every corner of medicine to
reaffirm our commitment to these lifesaving vaccines,” the groups wrote.
Here’s what to know about some of the recent vaccine policy changes:
Flu shots and thimerosal
On Thursday, a vaccine advisory group handpicked by Kennedy recommended
that just about every American get a flu shot this fall.
But the group also said people should avoid shots containing thimerosal,
a preservative used only in large multi-dose vials that has been proven
to be safe. The ingredient isn’t used in single-dose flu shots, the type
of syringe used for about 95% of U.S. flu shots last season.
Status: Kennedy must sign off on the recommendations. Read more AP
coverage here.
How to get a COVID-19 shot
Universal access to updated COVID-19 shots for the fall remains unclear,
even after Kennedy's vaccine advisers were shown data showing how well
the vaccines are working.
Kennedy changed CDC guidance last month, saying the shots are no longer
recommended for healthy children and pregnant women — even though
doctors groups disagree. And the Food and Drug Administration has moved
to limit COVID-19 vaccinations among healthy people under age 65.
[to top of second column]
|
 Status: Upcoming advisory meetings,
regulatory decisions and policies from insurers and employers are
likely to influence access. Read more AP coverage here.
Expanded warnings on COVID-19 vaccine labels
At the request of the FDA, makers of the two leading COVID-19
vaccines on Wednesday expanded existing warnings about a rare heart
side effect mainly seen in young men.
Prescribing information from both Pfizer and Moderna had already
advised doctors about rare cases of myocarditis, a type of heart
inflammation that is usually mild. The FDA had asked the drugmakers
to add more detail about the problem and to cover a larger group of
patients.
Status: Labels are being updated now. Read more AP coverage here.
Changes considered for the childhood vaccine schedule
On Wednesday, Kennedy’s vaccine advisers said they would be
evaluating the “cumulative effect” of the children’s vaccine
schedule — the list of immunizations given at different times
throughout childhood.
The announcement reflected vaccine skeptics' messaging: that too
many shots may overwhelm kids’ immune systems. Scientists say those
claims have been repeatedly investigated with no signs of concern.
The American Academy of Pediatrics said it would continue publishing
its own vaccine schedule for children but now will do so
independently of the government advisory panel, calling it “no
longer a credible process.”
Status: The examination is in its early stages. Read more AP
coverage here.
All contents © copyright 2025 Associated Press. All rights reserved
 |
